We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Greiner Bio-One

The Preanalytics division develops, manufactures and distributes venous blood collection devices for hospitals, labor... read more Featured Products: More products

Download Mobile App





Greiner Bio-One Displays Range of Safety Products at MedLab

By LabMedica International staff writers
Posted on 31 Jan 2019
Print article
Image: The VACUETTE range of safety products (Photo courtesy of Greiner Bio-One).
Image: The VACUETTE range of safety products (Photo courtesy of Greiner Bio-One).
Greiner Bio-One (Kremsmünster, Austria) exhibited its wide range of VACUETTE safety products at MedLab Middle East 2019 held in Dubai, UAE, from February 4-7, 2019. MedLab is the flagship exhibition and congress of the MedLab Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US. The Medlab Series covers all disciplines in the laboratory department and provides a unique platform for the industry’s multi-level professionals to meet under one roof.

Needlestick injuries from contaminated puncture devices are the most common source of infection for diseases transmitted by blood or other bodily fluids and are still among the most common occupational accidents today. Greiner Bio-One Preanalytics has been developing a range of safety products to reduce the risk of contamination and needlestick injuries, providing protection against potential injury risks.

At MedLab Middle East 2019, Greiner Bio-One exhibited its VACUETTE safety blood collection sets, which are particularly suitable for blood collection from patients with difficult veins. An integrated safety mechanism that is already activated in the patient's vein provides even greater safety in the blood collection process. The VACUETTE safety blood collection sets are available in different needle sizes and tubing lengths.

Greiner Bio-One also displayed its VACUETTE QUICKSHIELD safety tube holder, which enables greater flexibility related to user and patient-specific requirements due to its rotating safety shield. Additionally, the holder’s ergonomic design provides the user with a better grip for puncturing. The safety shield can be activated either one-handed with the aid of a solid surface or simply with the thumb.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.